Global Blood Therapeutics (GBT) Tops Q1 EPS by 4c

May 4, 2022 5:59 PM EDT

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Global Blood Therapeutics (NASDAQ: GBT) reported Q1 EPS of ($1.26), $0.04 better than the analyst estimate of ($1.30). Revenue for the quarter came in at $55.16 million versus the consensus estimate of $56.14 million.

For earnings history and earnings-related data on Global Blood Therapeutics (GBT) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities